BellaSeno starts clinical trials of resorbable chest and breast implants Decision Makers
BellaSeno GmbH, an ISO 13485-certified MedTech company developing resorbable chest and breast implant scaffolds using additive manufacturing technologies, began two clinical trials of its products in Australia, which are sponsored by its Australian subsidiary BellaSeno Pty. Already, recruiting has started in Brisbane, Australia.